Breaking News Instant updates and real-time market news.

FISV

Fiserv

$116.76 /

+1.57 (+1.36%)

08:44
12/16/19
12/16
08:44
12/16/19
08:44

Morgan Stanley starts Fiserv at Equal Weight with $121 price target

Morgan Stanley analyst James Faucette initiated coverage of Fiserv with an Equal Weight rating and $121 price target, stating that he views it as a leading financial services technology provider with a good business and "interesting" merchant acquiring assets, but also thinks that upside to synergies from its recent acquisition is largely reflected in expectations. He also believes a high level of competitive investment will limit its synergy upside potential longer-term.

FISV Fiserv
$116.76 /

+1.57 (+1.36%)

12/16/19 Morgan Stanley
Fiserv initiated with an Equal Weight at Morgan Stanley
12/05/19 Stephens
Fiserv price target raised to $124 from $117 at Stephens
12/03/19 BofA
Fiserv initiated with a Buy at BofA/Merrill
11/12/19 Oppenheimer
Fiserv pricet arget raised to $130 from $120 at Oppenheimer

TODAY'S FREE FLY STORIES

Upgrade
Chubb upgraded to Neutral from Underperform at BofA » 06:02
10/29/20
10/29
06:02
10/29/20
06:02
CB

Chubb

$127.34 /

+3.83 (+3.10%)

BofA upgraded Chubb to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

10/12/20 JPMorgan
Chubb upgraded to Overweight from Neutral at JPMorgan
10/12/20 JPMorgan
Travelers downgraded to Underweight from Neutral at JPMorgan
07/16/20 Evercore ISI
Chubb upgraded to Outperform from In Line at Evercore ISI
07/07/20 Wells Fargo
Chubb price target raised to $150 from $142 at Wells Fargo
CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

CB Chubb
$127.34 /

+3.83 (+3.10%)

Earnings
Spotify reports Q3 EPS (EUR 0.58) vs. EUR 0.36 last year » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
SPOT

Spotify

$276.35 /

-11.34 (-3.94%)

Reports Q3 revenue EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

10/27/20 Morgan Stanley
Spotify price target raised to $300 from $275 at Morgan Stanley
10/27/20 Deutsche Bank
Spotify price target raised to $250 from $240 at Deutsche Bank
10/14/20 Barclays
Spotify price target raised to $320 from $310 at Barclays
10/06/20 Credit Suisse
Sirius XM upgraded to Outperform from Neutral at Credit Suisse
SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

SPOT Spotify
$276.35 /

-11.34 (-3.94%)

Hot Stocks
Dr. Reddy's announces partnership with BIRAC for Sputnik V vaccine support » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
RDY

Dr. Reddy's

$64.82 /

-3.34 (-4.90%)

Dr. Reddy's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

09/18/20 Investec
Dr. Reddy's upgraded to Hold from Sell at Investec
09/03/20 Oppenheimer
Opco 'more skeptical' on Amarin patent win after 20 minute court hearing
09/02/20 Goldman Sachs
Oral arguments incrementally negative for Amarin, says Goldman Sachs
08/10/20 Oppenheimer
Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic
RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

RDY Dr. Reddy's
$64.82 /

-3.34 (-4.90%)

Hot Stocks
LKQ Corp. to resume share repurchase program in Q4  06:01
10/29/20
10/29
06:01
10/29/20
06:01
LKQ

LKQ Corp.

$29.81 /

-1.09 (-3.53%)

 
ShowHide Related Items >><<
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

09/11/20 Jefferies
LKQ Corp. price target raised to $42 from $35 at Jefferies
09/08/20 Stephens
LKQ Corp. price target raised to $40 from $35 at Stephens
07/15/20 SunTrust
LKQ Corp price target raised to $35 from $30 at SunTrust
06/19/20 JPMorgan
LKQ Corp. price target raised to $32 from $29 at JPMorgan
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

Earnings
LKQ Corp. reports Q3 adjusted EPS 75c, consensus 53c » 06:01
10/29/20
10/29
06:01
10/29/20
06:01
LKQ

LKQ Corp.

$29.81 /

-1.09 (-3.53%)

Reports Q3 revenue $3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

09/11/20 Jefferies
LKQ Corp. price target raised to $42 from $35 at Jefferies
09/08/20 Stephens
LKQ Corp. price target raised to $40 from $35 at Stephens
07/15/20 SunTrust
LKQ Corp price target raised to $35 from $30 at SunTrust
06/19/20 JPMorgan
LKQ Corp. price target raised to $32 from $29 at JPMorgan
LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

LKQ LKQ Corp.
$29.81 /

-1.09 (-3.53%)

Downgrade
First Solar downgraded to Neutral after 67% rally at JPMorgan » 06:00
10/29/20
10/29
06:00
10/29/20
06:00
FSLR

First Solar

$93.27 /

+10.89 (+13.22%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster downgraded First Solar to Neutral from Overweight with an unchanged price target of $94. After rallying 67% year-to-date, the stock is now trading close to the price target and at "historically-elevated" multiples, Coster tells investors in a research note. At the current multiple, and entering a later stage of the Series 6 product transition, focus shifts from sequential improvement in margins and profitability as production capacity fills in to whether First Solar has established a sustainable energy-density and cost/watt advantage in the global solar industry, says the analyst.

ShowHide Related Items >><<
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

FSLR First Solar
$93.27 /

+10.89 (+13.22%)

04:45 Today JPMorgan
First Solar downgraded to Neutral from Overweight at JPMorgan
10/28/20 Raymond James
First Solar price target raised to $90 from $80 at Raymond James
10/28/20 Roth Capital
First Solar price target raised to $110 from $100 at Roth Capital
10/28/20 Baird
First Solar price target raised to $125 from $97 at Baird
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

  • 17
    Sep
FSLR First Solar
$93.27 /

+10.89 (+13.22%)

FSLR First Solar
$93.27 /

+10.89 (+13.22%)

Earnings
KBR raises FY20 adj. EPS view to $1.60-$1.80 from $1.50-$1.80, consensus $1.68 » 05:59
10/29/20
10/29
05:59
10/29/20
05:59
KBR

KBR

$22.42 /

-0.795 (-3.42%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

10/27/20 Citi
KBR price target raised to $30 from $28 at Citi
06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

Periodicals
Amazon files motion to dismiss false advertising suit, Hollywood Reporter says » 05:59
10/29/20
10/29
05:59
10/29/20
05:59
AMZN

Amazon.com

$3,163.17 /

-123.35 (-3.75%)

Amazon has filed a motion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

10/27/20 Credit Suisse
Amazon.com price target raised to $3,700 from $3,680 at Credit Suisse
10/27/20 KeyBanc
Tapestry price target raised to $27 from $20 at KeyBanc
10/27/20 Deutsche Bank
Amazon.com price target raised to $4,050 from $4,000 at Deutsche Bank
10/26/20 Wedbush
Wedbush expects Amazon to report Q3 sales upside, record Q4
AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

AMZN Amazon.com
$3,163.17 /

-123.35 (-3.75%)

Downgrade
JPMorgan downgrades ChemoCentryx to Neutral after 'mixed' data » 05:58
10/29/20
10/29
05:58
10/29/20
05:58
CCXI

ChemoCentryx

$52.18 /

-0.26 (-0.50%)

JPMorgan analyst Anupam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

05:10 Today JPMorgan
ChemoCentryx downgraded to Neutral from Overweight at JPMorgan
04:52 Today Piper Sandler
ChemoCentryx price target raised to $71 from $67 at Piper Sandler
09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

  • 11
    Jun
CCXI ChemoCentryx
$52.18 /

-0.26 (-0.50%)

Earnings
KBR reports Q3 adj. EPS 44c, consensus 43c » 05:57
10/29/20
10/29
05:57
10/29/20
05:57
KBR

KBR

$22.42 /

-0.795 (-3.42%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

10/27/20 Citi
KBR price target raised to $30 from $28 at Citi
06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
KBR KBR
$22.42 /

-0.795 (-3.42%)

KBR KBR
$22.42 /

-0.795 (-3.42%)

Earnings
U.S. Concrete reports Q3 EPS $1.42, consensus 85c » 05:57
10/29/20
10/29
05:57
10/29/20
05:57
USCR

U.S. Concrete

$30.32 /

-2.83 (-8.54%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

04/21/20
DA Davidson uncertain on recovery time for U.S. Concrete, cuts to Neutral
04/21/20 DA Davidson
U.S. Concrete downgraded to Neutral from Buy at DA Davidson
04/20/20 SunTrust
U.S. Concrete price target lowered to $19 from $45 at SunTrust
04/20/20 Sidoti
U.S. Concrete downgraded to Neutral from Buy at Sidoti
USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

USCR U.S. Concrete
$30.32 /

-2.83 (-8.54%)

Hot Stocks
AbbVie presents upadacitinib data compared to placebo at EADV » 05:54
10/29/20
10/29
05:54
10/29/20
05:54
ABBV

AbbVie

$80.50 /

-2.19 (-2.65%)

Late-breaking data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

ABBV AbbVie
$80.50 /

-2.19 (-2.65%)

Upgrade
GB Group upgraded to Buy from Hold at Panmure Gordon » 05:47
10/29/20
10/29
05:47
10/29/20
05:47
GBGPF

GB Group

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBGPF GB Group
$0.00 /

+ (+0.00%)

10/20/20 Berenberg
GB Group upgraded to Buy from Hold at Berenberg
10/12/20 Citi
Citi opens 'positive catalyst watch' on GB Group
10/07/20 Canaccord
GB Group upgraded to Buy from Hold at Canaccord
07/01/20 Panmure Gordon
GB Group downgraded to Hold from Buy at Panmure Gordon
Earnings
Nokia reports Q3 non-IFRS EPS EUR0.05 vs. EUR0.05 last year » 05:46
10/29/20
10/29
05:46
10/29/20
05:46
NOK

Nokia

$4.06 /

-0.18 (-4.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

10/12/20 SEB Equities
Nokia upgraded to Buy from Hold at SEB Equities
09/29/20 Credit Suisse
Nokia price target lowered to EUR 3.65 from EUR 4 at Credit Suisse
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
09/08/20 Raymond James
Nokia downgraded to Market Perform from Strong Buy at Raymond James
NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

NOK Nokia
$4.06 /

-0.18 (-4.25%)

Downgrade
Beiersdorf downgraded to Hold from Buy at HSBC » 05:45
10/29/20
10/29
05:45
10/29/20
05:45
BDRFY

Beiersdorf

$0.00 /

+ (+0.00%)

HSBC analyst Jeremy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRFY Beiersdorf
$0.00 /

+ (+0.00%)

10/12/20 Bernstein
Beiersdorf initiated with an Outperform at Bernstein
10/02/20 Deutsche Bank
Beiersdorf price target lowered to EUR 100 from EUR 110 at Deutsche Bank
09/30/20 Barclays
Beiersdorf price target raised to EUR 115 from EUR 114 at Barclays
09/29/20 Berenberg
Beiersdorf upgraded to Hold from Sell at Berenberg
Hot Stocks
Exxon Mobil maintains quarterly dividend at 87c per share » 05:43
10/29/20
10/29
05:43
10/29/20
05:43
XOM

Exxon Mobil

$31.57 /

-1.26 (-3.84%)

Exxon Mobil last night…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 Goldman Sachs
Exxon Mobil upgraded to Neutral from Sell at Goldman Sachs
10/07/20 Societe Generale
SBM Offshore upgraded to Buy from Hold at Societe Generale
09/23/20 Scotiabank
Exxon Mobil upgraded to Sector Perform from Underperform at Scotiabank
XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

XOM Exxon Mobil
$31.57 /

-1.26 (-3.84%)

Hot Stocks
Moderna partners with Takeda to supply 50M doses of COVID-19 vaccine in Japan » 05:41
10/29/20
10/29
05:41
10/29/20
05:41
MRNA

Moderna

$65.75 /

-4.9 (-6.94%)

, TAK

Takeda Pharmaceutical

$16.11 /

-0.445 (-2.69%)

Moderna (MRNA) confirmed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

MRNA Moderna
$65.75 /

-4.9 (-6.94%)

TAK Takeda Pharmaceutical
$16.11 /

-0.445 (-2.69%)

Hot Stocks
Veon to sell Veon Armenia subsidiary to Team LLC » 05:38
10/29/20
10/29
05:38
10/29/20
05:38
VEON

Veon

$1.22 /

-0.045 (-3.57%)

Veon announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEON Veon
$1.22 /

-0.045 (-3.57%)

VEON Veon
$1.22 /

-0.045 (-3.57%)

09/22/20 VTB Capital
Veon upgraded to Buy from Hold at VTB Capital
08/06/20 New Street
Veon downgraded to Neutral from Buy at New Street
07/23/20 UBS
Veon downgraded to Neutral from Buy at UBS
03/27/20 VTB Capital
Veon upgraded to Buy from Hold at VTB Capital
  • 22
    Nov
Hot Stocks
American Public Education to acquire Rasmussen for $329M in cash, stock » 05:36
10/29/20
10/29
05:36
10/29/20
05:36
APEI

American Public Education

$27.57 /

-1.58 (-5.42%)

American Public Education…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APEI American Public Education
$27.57 /

-1.58 (-5.42%)

APEI American Public Education
$27.57 /

-1.58 (-5.42%)

08/12/20 BMO Capital
American Public Education price target raised to $38 from $33 at BMO Capital
05/29/20 Sidoti
American Public Education downgraded to Neutral on valuation at Sidoti
05/29/20 Sidoti
American Public Education downgraded to Neutral from Buy at Sidoti
05/13/20 BMO Capital
American Public Education price target raised to $33 from $20 at BMO Capital
APEI American Public Education
$27.57 /

-1.58 (-5.42%)

Periodicals
Marvell near deal to acquire Inphi for about $10B, WSJ reports » 05:31
10/29/20
10/29
05:31
10/29/20
05:31
IPHI

Inphi

$111.00 /

-2.92 (-2.56%)

, MRVL

Marvell

$39.54 /

-1.94 (-4.68%)

Marvell Technology Group…

Marvell Technology Group (MRVL) is nearing a deal to buy Inphi (IPHI) for as much as $10B and a deal could be announced as soon as Thursday, Cara Lombardo and Dana Cimilluca of Wall Street Journal report, citing people familiar with the matter. Buying Inphi would help Marvell expand its reach in networking, Lombardo and Cimilluca points out. Marvel will pay 60% of the acquisition in stock with the rest in cash, Liana Baker and Ian King of Bloomberg reported following the Journal's story. Shares of Inphi are up 36%, or $40.04, to $151.01 in premarket trading. Marvell is down 5%, or $1.86, to $37.67. Reference Link

ShowHide Related Items >><<
IPHI Inphi
$111.00 /

-2.92 (-2.56%)

MRVL Marvell
$39.54 /

-1.94 (-4.68%)

IPHI Inphi
$111.00 /

-2.92 (-2.56%)

10/12/20 B. Riley Securities
B. Riley prefers NeoPhotonics, Lumentum in optical component space
08/05/20 Northland
Inphi upgraded to Market Perform after earnings beat at Northland
08/05/20 Craig-Hallum
Inphi price target raised to $156 from $125 at Craig-Hallum
08/05/20 Northland
Inphi upgraded to Market Perform from Underperform at Northland
MRVL Marvell
$39.54 /

-1.94 (-4.68%)

10/20/20 KeyBanc
Marvell resumed with an Overweight at KeyBanc
10/13/20 Argus
Marvell showing accelerating momentum in 5G, says Argus
10/09/20 BMO Capital
Marvell price target raised to $42 from $32 at BMO Capital
10/09/20 Needham
Marvell price target raised to $47 from $39 at Needham
IPHI Inphi
$111.00 /

-2.92 (-2.56%)

MRVL Marvell
$39.54 /

-1.94 (-4.68%)

MRVL Marvell
$39.54 /

-1.94 (-4.68%)

IPHI Inphi
$111.00 /

-2.92 (-2.56%)

MRVL Marvell
$39.54 /

-1.94 (-4.68%)

MRVL Marvell
$39.54 /

-1.94 (-4.68%)

Hot Stocks
UMC enters plea agreement with DOJ, to pay $60M fine for stolen trade secret » 05:30
10/29/20
10/29
05:30
10/29/20
05:30
UMC

UMC

$5.52 /

-0.23 (-4.00%)

, MU

Micron

$49.98 /

-2 (-3.85%)

UMC (UMC) pleaded guilty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UMC UMC
$5.52 /

-0.23 (-4.00%)

MU Micron
$49.98 /

-2 (-3.85%)

UMC UMC
$5.52 /

-0.23 (-4.00%)

10/12/20 Credit Suisse
UMC upgraded to Outperform from Neutral at Credit Suisse
09/14/20 HSBC
UMC upgraded to Buy from Hold at HSBC
09/09/20 JPMorgan
UMC upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
UMC upgraded to Buy from Neutral at Goldman Sachs
MU Micron
$49.98 /

-2 (-3.85%)

10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
10/19/20 KeyBanc
Potential NAND business sale 'favorable' for Intel and sector, says KeyBanc
10/14/20 Citi
Micron margins could bottom this quarter, says Citi
10/12/20 Deutsche Bank
Micron upgraded to Buy from Hold at Deutsche Bank
UMC UMC
$5.52 /

-0.23 (-4.00%)

MU Micron
$49.98 /

-2 (-3.85%)

MU Micron
$49.98 /

-2 (-3.85%)

MU Micron
$49.98 /

-2 (-3.85%)

MU Micron
$49.98 /

-2 (-3.85%)

Hot Stocks
LVMH, Tiffany agree to reduced takeover price of $131.50 per share » 05:25
10/29/20
10/29
05:25
10/29/20
05:25
TIF

Tiffany

$129.85 /

+0.96 (+0.74%)

, LVMUY

LVMH

$0.00 /

+ (+0.00%)

LVMH Moet Hennessy Louis…

LVMH Moet Hennessy Louis Vuitton SE (LVMUY) and Tiffany & Co. (TIF) announced that they have concluded an agreement modifying certain terms of their initial agreement to reflect a purchase price of $131.50 in cash and to reduce closing conditionality. The original takeover price was $135 per share. Other key terms of the merger agreement remain unchanged, the companies said in a statement. Tiffany and LVMH have also agreed to settle their pending litigation in the Delaware Chancery Court. The boards of LVMH and Tiffany have approved the terms of the transaction and all required regulatory approvals have been obtained. The modified merger agreement provides that the regularly scheduled Tiffany quarterly dividend of 58c per share due to be declared on November 19 will be declared and paid. The merger is expected to close in early 2021, subject to Tiffany shareholder approval and customary closing conditions.

ShowHide Related Items >><<
TIF Tiffany
$129.85 /

+0.96 (+0.74%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$129.85 /

+0.96 (+0.74%)

10/28/20
LVMH, Tiffany near agreement on $131.50 per share price, WSJ reports
10/16/20 William Blair
Tiffany results strengthen legal standing against LVMH, says William Blair
09/10/20 Wells Fargo
Tiffany price target lowered to $120 from $135 at Wells Fargo
08/25/20 Oppenheimer
Opco 'turning more concerned' LVMH could reduce Tiffany buyout price
LVMUY LVMH
$0.00 /

+ (+0.00%)

10/28/20
LVMH, Tiffany near agreement on $131.50 per share price, WSJ reports
10/16/20 Morgan Stanley
LVMH price target raised to EUR 500 from EUR 465 at Morgan Stanley
10/16/20 UBS
LVMH price target raised to EUR 477 from EUR 462 at UBS
10/16/20 Credit Suisse
LVMH price target raised to EUR 475 from EUR 450 at Credit Suisse
TIF Tiffany
$129.85 /

+0.96 (+0.74%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$129.85 /

+0.96 (+0.74%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$129.85 /

+0.96 (+0.74%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$129.85 /

+0.96 (+0.74%)

Hot Stocks
Skanska invests $65M in Los Angeles development project » 05:24
10/29/20
10/29
05:24
10/29/20
05:24
SKSBF

Skanska

$0.00 /

+ (+0.00%)

Skanska invested…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKSBF Skanska
$0.00 /

+ (+0.00%)

SKSBF Skanska
$0.00 /

+ (+0.00%)

06/08/20 BofA
Skanska upgraded to Neutral from Underperform at BofA
05/14/20 UBS
Skanska price target lowered to SEK 160 from SEK 175 at UBS
Hot Stocks
Amryt Pharma announces Phase 3 EASE trial of Filsuvez meets primary endpoint » 05:21
10/29/20
10/29
05:21
10/29/20
05:21
AMYT

Amryt Pharma

$12.70 /

-0.15 (-1.17%)

Amryt announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMYT Amryt Pharma
$12.70 /

-0.15 (-1.17%)

AMYT Amryt Pharma
$12.70 /

-0.15 (-1.17%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
Upgrade
Criteo upgraded to Outperform from Market Perform at BMO Capital » 05:20
10/29/20
10/29
05:20
10/29/20
05:20
CRTO

Criteo

$14.03 /

+0.08 (+0.57%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRTO Criteo
$14.03 /

+0.08 (+0.57%)

CRTO Criteo
$14.03 /

+0.08 (+0.57%)

07/30/20 Citi
Criteo price target raised to $16 from $14 at Citi
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
05/08/20 Deutsche Bank
Criteo price target lowered to $16 from $22 at Deutsche Bank
05/05/20 SunTrust
Criteo price target lowered to $13 from $25 at SunTrust
CRTO Criteo
$14.03 /

+0.08 (+0.57%)

CRTO Criteo
$14.03 /

+0.08 (+0.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.